[EN] QUINAZOLINE AND QUINOLINE COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS QUINAZOLINE ET QUINOLÉINE, ET UTILISATIONS DE CEUX-CI
申请人:MILLENNIUM PHARM INC
公开号:WO2016118565A1
公开(公告)日:2016-07-28
This invention provides compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein T, J, R, R4, Rq, o, RA, W and RB and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, and/or T-cell mediated autoimmune disease.
这项发明提供了式(I)的化合物或其药用盐,其中T、J、R、R4、Rq、o、RA、W和RB及其子集如规范中所述。这些化合物是NAMPT的抑制剂,因此可用于治疗癌症、炎症性疾病和/或T细胞介导的自身免疫疾病。